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Abstract 
We report the construction and characterization of 
99m
Tc-labeled arginine-glycine-aspartic acid 
(RGD)-polyethylenimine (PEI) conjugates with entrapped gold nanoparticles in the cavities 
(RGD-
99m
Tc-Au PENPs) for dual mode SPECT/CT imaging of an orthotopic hepatic carcinoma 
model. In this study, PEI was successively decorated with diethylenetriaminepentaacetic acid, 
polyethylene glycol (PEG), and PEGylated RGD segments, and was utilized as an effective 
nanoplatform to entrap Au NPs and to be labelled with 
99m
Tc. We show that the designed 
RGD-
99m
Tc-Au PENPs display desirable colloidal stability and radiostability, and cytocompatibility 
in the investigated concentration range, and can be specifically uptaken by αvβ3 
integrin-overexpressing liver cancer cells in vitro. In vivo CT and SPECT imaging results indicate 
that the particles are able to be accumulated within an orthotopic hepatic carcinoma and display both 
CT and SPECT contrast enhancement in the tumor tissue. With the proven biocompatibility in vivo 
via histological examinations, the designed RGD-
99m
Tc-Au PENPs may be potentially employed as 
an effective nanoprobe for highly efficient dual mode SPECT/CT imaging of various αvβ3 
integrin-overexpressing tumors. 
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Introduction 
Hepatic carcinoma has been regarded as the 5
th
 common type of cancer and 3
rd
 common 
cancer-related deaths over the world, and it usually evolves from chronic liver disease.
1-3
 Imaging 
modalities for diagnosis of hepatic carcinoma mainly include ultrasonography,
4-5
 magnetic resonance 
(MR) imaging,
6-7
 computed tomography (CT)
8
 and nuclear imaging (e.g., single-photon emission 
computed tomography (SPECT)
9-10
 and positron emission tomography (PET)
11
). Development of 
effective contrast agents allowing for single mode or multi-mode diagnostic imaging is generally 
required to achieve precision imaging performances. 
Thanks to the unique structures and properties, nanoparticles (NPs) have been applied in 
different biomedical fields.
12-13
 Among these applications, NP-based contrast agents have been 
designed for CT,
14-15
 MR,
16-18
 SPECT
19-20
 and fluorescence imaging
21-22
 etc. in order to improve the 
resolution and sensitivity of these imaging modes. For instance, polyethylene glycol 
(PEG)-stabilized gold NPs (Au NPs, ~30 nm of diameter) were prepared and used as a contrast agent 
for effective blood pool/liver CT imaging.
23
 Au NPs having a diameter of 5 nm can be decorated 
with a peptide and doped with 
199
Au for targeted tumor SPECT imaging.
24
 Nevertheless, each 
imaging mode possesses its intrinsic virtues and drawbacks. CT imaging as a structural imaging 
mode can make a reconstruction of three-dimensional tomography with a high spatial resolution, but 
falls behind with poor soft-tissue contrast.
25
 In contrast, SPECT or PET imaging as a functional 
imaging mode displays a high sensitivity, along with an ability to trace in vivo particle 
biodistribution in real time,
26
 whereas it lacks spatial resolution. Therefore, to further improve the 
accuracy and sensitivity of tumor diagnosis, it is reasonable to make use of the strengths of both 
structural and functional imaging modalities by combining two or more imaging elements in one 
platform to fabricate dual- or multi-modality contrast agents. 
According to the literature reports, arginine-glycine-aspartic acid (RGD) peptide-targeted Au 
NPs loaded with gadolinium (Gd) and labeled with 
99m
Tc (RGD@AuNPs-Gd
99m
Tc) can be prepared 
with different sizes (29, 51, or 80 nm) for targeted MR/SPECT dual mode imaging-guided 
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radiosensitization therapy of tumor angiogenesis.
27
 RGD-conjugated 
99m
Tc-labeled Au NPs 
(diameter = 20 nm) via a spontaneous reaction of the thiol group have been designed for tumor 
SPECT/CT imaging applications.
28
 Citrated-coated [
64
Cu]CuS NPs with a diameter of 11 nm can be 
modified with PEG to have a good stability for micro-PET/CT dual mode imaging and photothermal 
therapy of tumors due to their strong near-infrared absorption peak at 930 nm.
29
 Moreover, it is well 
documented that tumor uptake of particles through the passive enhanced permeability and retention 
(EPR) effect is less efficient than that through active targeting. Hence, active targeting is inevitable 
to acquire better resolution of diagnostic imaging.
30-34
 However, it is still challengeable to develop 
such multifunctional NPs with two or more imaging elements incorporated and functional moieties 
such as targeting ligands modified on the same NP systems. The key factor is to use a proper 
platform which facilitates conjugation, encapsulation or stabilization of the imaging element and 
modification of functional groups on the surface of NPs. 
 Branched polyethylenimine (PEI), having abundant amines and good water solubility, has been 
widely used as a nanoplatform to coat NPs or load drug molecules for different biomedical 
applications.
35-39
 In our previous study, we demonstrate that PEI can be used as a template to entrap 
Au NPs for CT imaging,
40-42
 or be used as a stabilizer to coat the surface of iron oxide (or 
manganese oxide) NPs for MR imaging.
43-45
 It is logical to speculate that PEI may serve as a 
versatile nanoplatform to load both Au NPs (for CT imaging) and 
99m
Tc (for SPECT imaging) for 
dual mode SPECT/CT imaging of hepatic carcinoma. 
The aim of the current work was to fabricate RGD peptide-targeted PEI-entrapped Au NPs 
labeled with 
99m
Tc (RGD-
99m
Tc-Au PENPs) for highly efficient SPECT/CT imaging of an orthotopic 
hepatic carcinoma model. We prepared the multifunctional RGD-
99m
Tc-Au PENPs and fully 
characterize them by means of different techniques. Cell counting kit-8 (CCK-8) assay and confocal 
microscopic imaging of cell morphology were used to assess the cytotoxicity of the particles. 
HCC-LM3 cells (a human hematoma cell line) overexpressing αvβ3 integrin were utilized to confirm 
the specific targeting property of the RGD-conjugated nanoprobes in vitro. In vivo CT and SPECT 
imaging were utilized to check their potential to be employed for efficient SPECT/CT imaging of an 
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orthotopic human hepatic carcinoma model. A thorough literature investigation leads us to claim that 
this is the very first trial dealing with the preparation of RGD-functionalized and 
99m
Tc-labeled Au 
PENPs for dual mode SPECT/CT imaging of tumors. 
Experimental Section 
Synthesis of PEI.NH2-DTPA-mPEG-(PEG-RGD). RGD-PEG-COOH was prepared in line 
with the literature.
46
 To prepare the PEI.NH2-DTPA-mPEG-(PEG-RGD) conjugate, DTPA (7.14 mg, 
5 mL DMSO) was added into a PEI DMSO solution (50 mg, 10 mL) under stirring for 1 day. 
Afterwards, mPEG-COOH (80 mg, 8 mL DMSO) was activated by 76.7 mg of 
1-ethyl-3-(3-dimethylaminopropy) carbodiimide hydrochloride (EDC) and 46.0 mg of 
N-hydroxysuccinimide (NHS) and added to the above PEI.NH2-DTPA solution, and then the above 
solution was magnetically stirred for another 3 days to obtain the raw product of 
PEI.NH2-DTPA-mPEG. Lastly, the EDC/NHS-activated RGD-PEG-COOH (51 mg, 7 mL DMSO) 
was added to the above PEI.NH2-DTPA-mPEG solution under stirring for 3 days. The prepared 
PEI.NH2-DTPA-mPEG-(PEG-RGD) mixture was purified by dialysis and lyophilized to get a 
powder in accordance with our previous work.
42
 
Synthesis of RGD-
99m
Tc-Au PENPs. The formed PEI.NH2-DTPA-mPEG-(PEG-RGD) was 
used as an effective template for the entrapment of Au NPs. In brief, HAuCl4 (10 mg/mL, in 8.24 
mL water) with 200 molar equiv. of PEI.NH2-DTPA-mPEG-(PEG-RGD) was firstly added slowly to 
the PEI.NH2-DTPA-mPEG-(PEG-RGD) water solution (76.9 mg, 200 mL) with vigorous stirring for 
about 15 min. Then, the icy NaBH4 (4.7 mg, 5 mL) water solution was quickly dropped into the 
above Au(III) salt/PEI.NH2-DTPA-mPEG-(PEG-RGD) mixture solution, followed by continuous 
agitation for 3 h. The formed {(Au
0
)200-PEI.NH2-DTPA-mPEG-(PEG-RGD)} was acetylated to 
prepare {(Au
0
)200-PEI.NHAc-DTPA-mPEG-(PEG-RGD)} PENPs (for short, RGD-Au PENPs) 
according to the literature.
42
 The mixture was then purified in line with our previous work.
42
 
The formed RGD-Au PENPs were then labeled with 
99m
Tc through DTPA chelation. In brief, the 
RGD-Au PENPs solution (1 mg/mL, in 3 mL PBS) was initially added into an SnCl2 PBS solution 
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(50 mg/mL, 2 mL) under stirring for 8 min, and then sterile TcO4
-
 salt (700 MBq/mL, 1 mL) was 
added under stirring for another 5 min. Lastly, the formed 
{(Au
0
)200-PEI.NHAc-DTPA(
99m
Tc)-mPEG-(PEG-RGD) PENPs (for short, RGD-
99m
Tc-Au PENPs) 
was purified using PD-10 desalting columns according to our previous work.
47
 
Cytotoxicity Assays. We used standard CCK-8 assay method to test the cytocompatibility of 
the particles reported in the literature.
48
 Similarly, HCC-LM3 cells were cocultured with the 
RGD-Au PENPs ([Au] = 0-200 µM) for 24 h, followed by rinsing with PBS, paraformaldehyde 
fixation, and 4',6-diamidino-2-phenylindole (DAPI) staining. The cell morphology was viewed 
under a Leica DM IL LED inverted phase contrast microscope (Wetzlar, Germany). To check how 
the particles impacted on the cytoskeleton, HCC-LM3 cells were seeded on cover slips in a 12-well 
plate with 1 mL of fresh Dulbecco’s modified Eagle medium (DMEM) for each well for 12 h. The 
cells were treated using protocols in our previous work
49
 before confocal microscopic observation. 
Cell Immunohistochemistry. 5 × 10
4 
HCC-LM3 cells and L929 cells (a mouse fibroblast cell 
line, as negative control cells) were cultured onto each cover slip in a 12-well plate with 1 mL of 
fresh DMEM for each well for 24 h, respectively. After being washed twice and fixed, the cells were 
rinsed 3 times and treated with 3% H2O2 for 15 min. After that, the cells in each well were washed, 
added with 300 µL of immunostaining mounting medium, and incubated for another 20 min. Next, 
the mounting medium was carefully removed, and primary αvβ3 integrin antibody (mouse 
anti-human, 1: 200) was added to each well, and the cells were cultured overnight in dark at 4 
o
C. 
Hereafter, the cells were washed with PBS for three times, and incubated with red fluorescent 
AF594-labeled secondary antibody (goat anti-mouse, 1:200) for 1 h at 37
 o
C in dark. Finally, the 
cells were rinsed and stained with DAPI for 10 min before confocal microscopic imaging. These 
L929 cells and HCC-LM3 cells were both treated with or without primary antibody, respectively. 
CT Imaging of an Orthotopic Hepatic Carcinoma Model in Vivo. Animal experiments were 
performed following both requirements of the institutional committee for animal care and the 
National Ministry of Health. Both nude mice and C57BL/6 mice were purchased from Shanghai 
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SLAC Laboratory Animal Center (Shanghai, China). An orthotopic hepatic carcinoma model was 
established on nude mice according to our previous protocol.
50
 In brief, 5 × 10
6
 HCC-LM3 cells 
were first subcutaneously injected into the right flank of each nude mouse (6-week-old) to establish 
a subcutaneous HCC-LM3 tumor transplantation model. The tumor was extracted after its volume 
reaches up to 200-300 mm
3
. Then, the tumor was cut into small pieces with a dimension of 1 mm
3
, 
and planted into the liver of each nude mouse to establish an orthotopic hepatic carcinoma model. 
We then intravenously injected the RGD-Au PENPs or Au PENPs ([Au] = 0.1 M, in 150 µL PBS) to 
each tumor-bearing mouse via tail vein after the mouse was anesthetized. The mice were then put 
into a CT scanning holder, and scanning was then performed according to the literature.
40
 
SPECT/CT Imaging of an Orthotopic Hepatic Carcinoma Model in Vivo. The synthesized 
RGD-
99m
Tc-Au PENPs or nontargeted 
99m
Tc-Au PENPs (600 µCi 
99m
Tc, in 150 µL PBS) were 
intravenously delivered to each mouse after anesthetization. Then, the mice were scanned by a 
SPECT/CT imaging system using a Nano SPECT/CT in Vivo Animal Imager (Bioscan Ltd., 
Washington, D.C.) with 80 kV, 450 µA and slice thickness of 45 µm. 
 
Results and Discussion 
Construction and Characterization of the RGD-
99m
Tc-Au PENPs. DTPA, mPEG-COOH, 
and RGD-PEG-COOH were successively modified onto the PEI surface to synthesize 
PEI.NH2-DTPA-mPEG-(PEG-RGD). Then the PEI.NH2-DTPA-mPEG-(PEG-RGD) was employed 
as a desirable nanoreactor to entrap Au NPs, and the formed Au PENPs were acetylated to neutralize 
the remaining PEI amines and chelated with 
99m
Tc (Scheme 1). The prepared RGD-Au PENPs and 
RGD-
99m
Tc-Au PENPs were characterized through various techniques. 
Firstly, the structures of the RGD-PEG-COOH, PEI.NH2-DTPA, 
PEI.NH2-DTPA-mPEG-(PEG-RGD), and RGD-Au PENPs were characterized via NMR (Figure S1, 
Supporting Information). The peaks at 3.5-3.6 ppm belong to -CH2- protons of PEG, and 5.8-7.3 
ppm to the benzene ring of RGD protons (Figure S1a). According to the NMR peak integration, each 
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PEG was estimated to have 0.78 RGD moieties linked. Likewise, NMR integration shows that each 
PEI (δ: 2.2-3.5 ppm) has 9.5 DTPA (δ: 3.0-3.4 ppm), 22.4 PEG, and 5.2 RGD moieties linked 
(Figure S1b-c). After the remaining amines of RGD-Au PENPs were acetylated, the peaks of acetyl 
protons located at 1.8-2.2 ppm appears (Figure S1d), which can be assigned to the primary and 
secondary PEI amides.
41
 
 
Scheme 1. Schematic diagram of the construction of RGD-
99m
Tc-Au PENPs. 
 
Furthermore, the surface potential of both RGD-Au PENPs (9.13 ± 0.16 mV) and Au PENPs 
(12.05 ± 0.52 mV) were measured to be slightly positive after acetylation modification of the PEI 
amines (Table S1, Supporting Information). In addition, ultraviolet-visible (UV-vis) spectrometry  
was used to confirm the formation of Au NPs (Figure S2, Supporting Information), where both 
RGD-Au PENPs and Au PENPs possess a surface plasmon resonance (SPR) peak at 515 nm that can 
be assigned to the Au NPs. 
Next, we used TEM to characterize the shape and size of the prepared RGD-Au PENPs and Au 
PENPs (Figure 1). Both particles show a round shape with a uniform size distribution. High 
resolution TEM images reveal that both particles are highly crystalline, as their lattice structures can 
be clearly discerned (see insets of Figure 1). The diameters of RGD-Au PENPs and Au PENPs were 
measured to be 2.6 nm and 2.2 nm, respectively, which are quite smaller than the hydrodynamic size 
of the corresponding particles as measured by DLS (95.7 nm for Au PENPs, and 138 nm for 
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RGD-Au PENPs, see Table S1). This is likely because only single Au core particles are measured by 
TEM, whereas DLS measures the clustered particles of PENPs, which may consist of many single 
Au NPs, in accordance with the literature.
8
 What’s more, the prepared RGD-Au PENPs show an 
excellent colloidal stability for at least 7 days after dispersion in water, PBS or cell culture medium 
at 4 
o
C (Figure S3, Supporting Information). 
 
Figure 1. TEM images (a, c) and size distribution histograms (b, d) of the RGD-Au PENPs (a, b) 
and nontargeted Au PENPs (c, d), respectively. Inset in panels (a, c) show the high-resolution TEM 
images of the Au core particles of RGD-Au PENPs (a) and Au PENPs (c). 
 
The formed RGD-Au PENPs were then labeled with 
99m
Tc through DTPA chelation to obtain 
the RGD-
99m
Tc-Au PENPs (Scheme 1). The labeling yield for the RGD-Au PENPs and Au PENPs 
was determined to be 71.3 ± 4.7% (n = 3) and 69.6 ± 4.8% (n = 3), respectively. The radiostability of 
the RGD-
99m
Tc-Au PENPs in PBS solution was assessed by measuring the radiochemical purity of 
the NPs at different time periods (Figure S4, Supporting Information). Apparently, the purity of the 
NPs remains 99% at different storage time periods, indicating that the designed RGD-
99m
Tc-Au 
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PENPs display a great radiostability. 
X-ray Attenuation Property of the RGD-Au PENPs. We tested the X-ray attenuation property 
of the prepared RGD-Au PENPs to confirm their CT imaging potential (Figure S5, Supporting 
Information). Omnipaque was also tested for comparison. Generally, Au NPs show a better X-ray 
attenuation property than Omnipaque owing to the fact that Au has a higher atomic number (Z = 79) 
and a k-edge value (80.4 keV) than those of iodine for Omnipaque (Z = 53, 33.2 keV).
15, 51-52
 As 
expected, the RGD-Au PENPs display a linearly increased CT contrast enhancement with the 
increase of Au concentration, similar to the case of Omnipaque as a function of iodine concentration. 
Meanwhile, the CT values of the RGD-Au PENPs are higher than that of Omnipaque under identical 
imaging element (iodine or Au) concentrations, particularly in relatively high concentrations of 
imaging element (e.g., at 0.1M, 818 HU of RGD-Au PENPs vs. 596 HU of Omnipaque), in 
consistence with the literature.
41-42
 
 
Figure 2. CCK-8 assay of HCC-LM3 cells after co-cultured with RGD-Au PENPs at the Au 
concentrations of 0-200 µM for 24 h (a). Confocal microscopic images of HCC-LM3 cells 
co-cultured with RGD-Au PENPs at the Au concentrations of 0 µM (b), 50 µM (c), 100 µM (d), and 
200 µM (e), respectively for 24 h (the cytoplasm was stained with phalloidin-rhodamine, and the cell 
nuclei were stained with DAPI). 
 
Cytotoxicity Assays. We used CCK-8 assay (Figure 2a) and morphology observation of cells 
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(Figure S6, Supporting Information) to evaluate the cytotoxicity of the RGD-Au PENPs. Results 
show that the viability and morphology of HCC-LM3 cells are pretty similar to the PBS control after 
the cells were co-cultured with the RGD-Au PENPs at different Au concentrations. 
The cytoskeleton and nucleus of cells were also observed after being treated with RGD-Au 
PENPs (Figure 2b-e). The cells treated with the RGD-Au PENPs maintain the normal cytoskeleton 
and nucleus morphology without and cytoskeleton disruption or cellular membrane dysfunction, 
similar to the PBS control. Taken together, we can safely conclude that the designed RGD-Au 
PENPs possess an excellent cytocompatibility in the studied concentration range. 
 
Figure 3. Immunocytochemistry of αvβ3 integrin receptor in L929 cells (negative cells; a, treated 
without primary antibody; b, treated with primary antibody) and HCC-LM3 cells (c, treated without 
primary antibody; d, treated with primary antibody). The cell nuclei were stained with DAPI, the cell 
membranes were stained with AF594-labeled secondary antibody. 
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Cell Immunohistochemistry. To confirm if the HCC-LM3 cells have expression of αvβ3 
integrin, we performed cell immunohistochemistry assays (Figure 3). The HCC-LM3 cells treated 
with both primary αvβ3 integrin antibody and secondary AF594-labeled antibody display apparent 
red fluorescence signals (Figure 3d), which are associated to the expression of αvβ3 integrin on the 
surface of the HCC-LM3 cells. In sharp contrast, the negative control cells (L929 cells) treated with 
or without primary antibody but with the secondary antibody hardly display any red fluorescence 
signals (Figures 3a and 3b), suggesting that the L929 cells do not have αvβ3 integrin expression on 
their membranes. Moreover, the HCC-LM3 cells treated without the primary antibody do not display 
any red fluorescence signals even after treated with the secondary antibody (Figure 3c). These 
results indicate that αvβ3 integrin receptor overexpression can be found on the surface of HCC-LM3 
cells. Thus, in theory, RGD-functionalized NPs should have targeting specificity to the αvβ3 integrin 
receptor-overexpressing cancer cells in vitro. It should be noted that due to the plane scanning mode 
of the confocal or fluorescence microscopy, in most cases, a small portion of fluorescence signals 
can often be found in the cytosol, even if only the cell membranes are stained, in agreement with the 
literature.
53-54
 
Cellular Uptake. We use ICP-OES to explore whether the designed RGD-Au PENPs can be 
specifically taken up by hepatic carcinoma cells that overexpress αvβ3 integrin in vitro. As shown in 
Figure 4, the Au uptake by HCC-LM3 cells co-cultured with the RGD-Au PENPs is obviously 
higher than that co-cultured with the Au PENPs without RGD at the same Au concentrations (e.g., 
4.90 ± 0.18 pg/cell for RGD-Au PENPs ([Au] = 200 µM) vs. 3.82 ± 0.17 pg/cell for Au PENPs ([Au] 
= 200 µM), p < 0.01). Furthermore, the pre-incubation of free RGD peptide with the HCC-LM3 cells 
leads to a much lower cellular Au uptake after incubated with the targeted RGD-Au PENPs than 
direct treatment of cells with the RGD-Au PENPs at the same Au concentrations. In addition, there 
is no significant difference in the Au uptake by HCC-LM3 cells treated with the non-targeted Au 
PENPs and RGD-Au PENPs with free RGD peptide cultivation at the same Au concentrations (e.g., 
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1.94 ± 0.15 pg/cell for RGD-Au PENPs (+RGD, [Au] = 100 µM) vs. 2.00 ± 0.15 pg/cell for Au 
PENPs ([Au] = 100 µM), p > 0.05). These results show that free RGD peptide is able to bind the 
overexpressed αvβ3 integrin of HCC-LM3 cells, thus blocking the targeting of the RGD-Au PENPs. 
This demonstrates that the formed RGD-Au PENPs are able to specifically recognize the αvβ3 
integrin receptor-overexpressing cancer cells in vitro through receptor-mediated active targeting 
effect, which is important for their applications for highly efficient tumor CT and SPECT/CT 
imaging. 
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Figure 4. Au uptake in HCC-LM3 cells treated with Au PENPs, RGD-Au PENPs (+RGD, pretreated 
with free RGD peptide to block the targeting of the RGD-Au PENPs) or RGD-Au PENPs at 
different Au concentrations. 
 
CT Imaging of an Orthotopic Hepatic Carcinoma Model. CT scanning was carried out both 
before and after the hepatic carcinoma bearing-mice were intravenously injected with the RGD-Au 
PENPs and non-targeted Au PENPs (Figure 5). The hepatic carcinoma region shows an obvious CT 
contrast enhancement after injection with these two particles (Figure 5a, and for anatomical picture 
of the tumor, see Figure 5b). At 0.5 h postinjection, the tumor CT value reaches the maximum (47.1 
± 1.8 HU for RGD-Au PENPs, and 32.6 ± 2.5 HU for Au PENPs), and then begins to decrease 
slightly due to the metabolic process (Figure 5c). Strikingly, the tumor CT values of the mouse 
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delivered with the RGD-Au PENPs are much greater than those delivered with the non-targeted Au 
PENPs at the same time points (p < 0.05). In addition, the CT values of normal liver are much 
greater than the orthotopic hepatic carcinoma at the same time point postinjection, presumably due 
to the fact that these particles are mainly cleared by reticuloendothelial system (RES) located in the 
liver (Table S2, Supporting Information). The CT values of normal liver decrease with time 
postinjection, and no significance difference in CT values of normal liver can be seen after injection 
of the two particles (Table S2, Supporting Information). These observations imply that the 
RGD-functionalized Au PENPs can be efficiently taken up by αvβ3 integrin receptor-overexpressing 
tumor cells, resulting in enhanced orthotopic hepatic carcinoma CT imaging. 
 
Figure 5. In vivo CT images (a) and CT values (c) of an orthotopic hepatic carcinoma model after 
intravenous administration of the RGD-Au PENPs or nontargeted Au PENPs ([Au] = 0.1 M, 150 µL 
PBS for each mouse) at different time points postinjection (red circle refers to the hepatic carcinoma 
region, white circle refers to normal liver region); (b) a photo of nude mouse bearing an orthotopic 
hepatic carcinoma (blue triangle refers to hepatic carcinoma region). 
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SPECT/CT Imaging of an Orthotopic Hepatic Carcinoma Model. Owing to the labeling of 
radioactive 
99m
Tc, the formed RGD-
99m
Tc-Au PENPs were next used for dual mode SPECT/CT 
imaging of an orthotopic hepatic carcinoma model. In this context, CT was just used to localize the 
skeleton of the mice. As shown in Figure 6a, the normal liver is much brighter than the hepatic 
carcinoma area (indicated with green circles) after injection, which is similar to the results of CT 
imaging. Moreover, the SPECT signal intensity of hepatic carcinoma region reaches the peak value 
(50.2 ± 0.8 µCi/mm
3
 of RGD-
99m
Tc-Au PENPs, 44.5 ± 1.3 µCi/mm
3 
of 
99m
Tc-Au PENPs) at 0.5 h 
postinjection of the NPs, then gradually reduces with time (Figure 6b). More importantly, 
RGD-
99m
Tc-Au PENPs generated much greater SPECT signal intensity of hepatic carcinoma than 
the non-targeted 
99m
Tc-Au PENPs at the same time point postinjection (Figure 6b), in accordance 
with the quantitative CT imaging data (Figure 5c). Our results further confirm that RGD-
99m
Tc-Au 
PENPs can be more efficiently taken up by αvβ3 integrin receptor-overexpressing tumor cells in 
hepatic carcinoma than the non-targeted 
99m
Tc-Au PENPs. We also find that the SPECT signal 
intensity of normal liver decreases with time postinjection of these two particles, and is much higher 
than that of the orthotopic hepatic carcinoma at the same time points, which is consistent with CT 
imaging data (Table S3, Supporting Information). It is interesting to note that we are attempting to 
highlight difference between the liver tumor region after injection of RGD-modified Au PENPs and 
non-targeted Au PENPs, instead to highlight the difference between the normal liver region and the 
liver tumor. In this case, we do not necessarily have to care about the difference of Au uptake in liver 
and liver tumor. In general, it is very difficult to reverse the trend that the PEGylated NPs are mainly 
taken up by the reticuloendothelial system (RES) and Kupffer cells of the liver and spleen,
23, 55
 even 
though the NPs are functionalized with targeting ligands. It is also worth noting that the designed 
RGD-
99m
Tc-Au PENPs are more advantageous than the commercial 
99m
Tc-sulfur colloids 
(www.pharmalucence.com) in several aspects. First, our designed PEI-based nanoplatform is easily 
functionalized with targeted ligands to achieve specific targeting to cancer cells or can be combined 
with other imaging elements to realize multi-mode imaging, while 
99m
Tc-sulfur colloid hardly 
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realizes multifunctionality. Second, the stability of the 
99m
Tc-sulfur colloid may be limited in the 
presence of the polyvalent cations, while the RGD-
99m
Tc-Au PENPs we prepared have a good 
stability in PBS. Thirdly, the 
99m
Tc sulfur colloid is rapidly cleared by the RES from the blood with a 
half-life of approximately 2.5 min, while the half-life of PEGylated Au PENPs is 11.2 h,
41
 which is 
sufficiently long for their effective uses in CT/SPECT imaging of HCC. 
 
Figure 6. In vivo SPECT/CT images (a) and SPECT signal intensity (b) of the orthotopic hepatic 
carcinoma (noted as green circle) after intravenous administration of the RGD-
99m
Tc-Au PENPs or 
99m
Tc-Au PENPs (600 µCi 
99m
Tc, in 150 µL PBS for each mouse) at different time points 
postinjection. 
 
In Vivo Biodistribution and Toxicity Evaluation. To further validate the imaging results, we 
investigated the in vivo biodistribution of Au after administration of the Au PENPs (Figure S7, 
Supporting Information). Clearly, at 24 h postinjection, the RGD-Au PENPs are mainly taken up by 
spleen (1078.6 ± 121 µg/g) and liver (727.9 ± 90.1 µg/g), in accordance with the in vivo imaging 
results. In addition, no significant difference in Au uptake of organs between the RGD-Au PENPs 
and nontargeted Au PENPs is observed (e.g., 727.9 ± 90.1 µg/g for RGD-Au PENPs vs. 772.9 ± 
78.3 µg/g for nontargeted Au PENPs in normal liver, p > 0.05). In contrast, the Au uptake in the 
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hepatic carcinoma region treated with the RGD-Au PENPs (310.9 ± 35.8 µg/g) is much greater than 
that treated with the non-targeted Au PENPs (233.1 ± 21.2 µg/g). This means that due to the 
RGD-mediated targeting, the developed RGD-Au PENPs can be used as a nanoprobe for enhanced 
tumor imaging. It should be noted that the in vivo biodistribution data were obtained at 24 h 
postinjection, whereas the SPECT/CT imaging data were collected at 5 h postinjection (for the latest 
time point). It is envisioned that the particles have already undergone a metabolic process at 24 h 
postinjection, and hence the difference between tumor uptake of the RGD-modified Au PENPs and 
non-targeted Au PENPs should be less, but still have a significant difference.  
The long-term in vivo toxicity of the RGD-Au PENPs to major organs of the healthy mice was 
examined by H&E staining. Clearly, no histological change can be observed in the major organ 
slices including heart, liver, lung, spleen, and kidney at 30 days postinjection, compared with the 
PBS control (Figure S8, Supporting Information), demonstrating that the prepared RGD-Au PENPs 
possess good biocompatibility in vivo. 
 
Conclusions 
To conclude, we developed a versatile PEI-based nanoplatform for dual mode SPECT/CT 
imaging of an orthotopic tumor model. Branched PEI can be conveniently modified with DTPA to 
label 
99m
Tc for SPECT imaging, entrapped with Au NPs after surface PEGylation modification for 
CT imaging, and be decorated with RGD peptide through a PEG spacer to endow the particles with 
specific targeting capacity to cancer cells expressing αvβ3 integrin in vitro. The designed RGD-Au 
PENPs with an Au core diameter of 2.6 nm are colloidally stable, cytocompatible, and can be 
utilized for CT imaging of the orthotopic hepatic carcinoma model. Furthermore, radioisotope of 
99m
Tc can be efficiently labeled onto the RGD-Au PENPs via chelation to have desirable labelling 
efficiency and radiostability for highly efficient SPECT imaging of the orthotopic tumor model. The 
designed RGD-
99m
Tc-Au PENPs hold a great promise to be employed as an effective nanoprobe for 
dual mode SPECT/CT imaging of different αvβ3 integrin receptor-overexpressing tumors. 
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Supporting Information 
Additional DLS and zeta-potential data; in vivo CT values or SPECT signal intensity of normal liver; 
1
H NMR; UV-vis spectra; stability assessment of RGD-Au PENPs; radiochemical purity analysis; 
CT images and X-ray attenuation intensity of the RGD-Au PENPs; fluorescence microscopic images 
of HCC-LM3 cells; in vivo biodistribution of the materials; and H&E staining. This material is 
available free of charge via the Internet at http://pubs.acs.org. 
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